Essential role of Dhx16-mediated ribosome assembly in maintenance of hematopoietic stem cells
Leukemia · 2024
DOI: 10.1038/s41375-024-02423-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Leukemia, 2024. Verfasst von Zhigang Li und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiological Medicine, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, China. Hauptthemen laut MEDLINE: Hematopoietic Stem Cells, Ribosomes, Mice, Knockout. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China (National Science Foundation of China).
Abstract (Originalsprache)
Hematopoietic stem cells (HSCs) are vital for the differentiation of all mature blood cells, with their homeostasis being tightly regulated by intrinsic and extrinsic factors. Alternative splicing, mediated by the spliceosome complex, plays a crucial role in regulating HSC homeostasis by increasing protein diversity. This study focuses on the ATP-dependent RNA helicase DHX16, a key spliceosome component, and its role in HSC regulation. Using conditional knockout mice, we demonstrate that loss of Dhx16 in the hematopoietic system results in significant depletion of hematopoietic stem and progenitor cells, bone marrow failure, and rapid mortality. Dhx16-deficient HSCs exhibit impaired quiescence, G2-M phase cell cycle arrest, reduced protein synthesis, abnormal ribosome assembly, increased apoptosis, and decreased self-renewal capacity. Multi-omics analysis identified intron 4 retention in Emg1 mRNA in Dhx16 knockout HSCs, leading to reduced EMG1 protein expression, disrupted ribosome assembly, and nucleolar stress, activating the p53 pathway. Overexpression of Emg1 in Dhx16-deficient HSCs partially restored ribosome assembly and HSC function, suggesting Emg1 as a potential therapeutic target for ribosomopathies. Our findings reveal the critical role of Dhx16 in HSC homeostasis through the regulation of alternative splicing and ribosome assembly, providing insights into the molecular mechanisms underlying hematopoietic diseases and potential therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiological Medicine, School of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, China.
- Department of Clinical Hematology, Third Military Medical University (Army Medical University), Chongqing, 400038, China.
- Department of Hematology, Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China.
- Chongqing BI Academy, Chongqing, 401127, China.
- Leicester Medical School, University of Leicester College of Life Sciences, Leicester, Leicester, UK. zhanhan.tu@leicester.ac.uk.
- University of Leicester Ulverscroft Eye Unit, School of Psychology and Vision Sciences, University of Leicester College of Life Sciences, Leicester, Leicester, UK. zhanhan.tu@leicester.ac.uk.
ORCID-Profile: Yu Hou
Förderung
- National Natural Science Foundation of China (National Science Foundation of China)
Zitieren
APA
Li, Z., Fan, J., Xiao, Y., Wang, W., Zhen, C., Pan, J., Wu, W., Liu, Y., Chen, Z., Yan, Q., Zeng, H., Luo, S., Liu, L., Tu, Z., Zhao, X., & Hou, Y. (2024). Essential role of Dhx16-mediated ribosome assembly in maintenance of hematopoietic stem cells. Leukemia. https://doi.org/10.1038/s41375-024-02423-3
Vancouver
Li Z, Fan J, Xiao Y, Wang W, Zhen C, Pan J, et al. Essential role of Dhx16-mediated ribosome assembly in maintenance of hematopoietic stem cells. Leukemia. 2024. doi:10.1038/s41375-024-02423-3
BibTeX
@article{Li2024,
author = {Li, Zhigang and Fan, Jiankun and Xiao, Yalan and Wang, Wei and Zhen, Changlin and Pan, Junbing and Wu, Weiru and Liu, Yuanyuan and Chen, Zhe and Yan, Qinrong and Zeng, Hanqing and Luo, Shuyu and Liu, Lun and Tu, Zhanhan and Zhao, Xueya and Hou, Yu},
title = {Essential role of Dhx16-mediated ribosome assembly in maintenance of hematopoietic stem cells},
journal = {Leukemia},
year = {2024},
doi = {10.1038/s41375-024-02423-3}
}
EUVIMED